Eliminating Interference from Autofluorescence in Flow Cytometry
消除流式细胞术中自发荧光的干扰
基本信息
- 批准号:10484468
- 负责人:
- 金额:$ 144.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcute Myelocytic LeukemiaAlgorithmic AnalysisAlgorithmic SoftwareAlgorithmsAntigensBenchmarkingBiologicalBiological AssayBiomedical ResearchCancer BiologyCell CountCell Membrane PermeabilityCellsClinicalCollectionColorColoradoCommunicable DiseasesDataData AnalysesDetectionDiagnosisDiagnosticDisciplineDyesEventExcisionFiberFlow CytometryFluorescenceFreeze DryingFundingGrantHumanImmunologistImmunologyImmunophenotypingKineticsLabelLaboratoriesLasersLeadLymphocyteMalignant NeoplasmsMeasuresMethodsMicrobiologyMicrospheresMolecular BiologyMonitorMyeloid CellsNADHOncologyOutputOxidation-ReductionPatientsPhasePloidiesResearchResearch PersonnelRiversSamplingShapesSignal TransductionSmall Business Innovation Research GrantSourceSpeedStainsSurfaceSystemTechnologyTestingTimeTumor BiologyUnited States National Institutes of HealthViolaanalogcancer immunotherapyclinically relevantcommercializationcomputerized data processingdata acquisitiondata handlingdata qualitydesigndrug developmentexperimental studyfluorophoreimprovedinstrumentnoveloptical spectraprogramsprototypereceptorresponsesignal processingstem cell therapytime resolved datatime usetool
项目摘要
PROJECT SUMMARY/ABSTRACT
Flow cytometry (FC) is a powerful cell analysis tool relying on fluorescently labeling of cells. It can provide
information on cell count, shape, size, DNA content, redox state, membrane permeability, and surface receptors,
among other features. FC is an essential tool in research and clinical fields for tumor biology research, cancer
and AIDS diagnostics, stem cell therapy, immunophenotyping, and cancer immunotherapy. One of the leading
limitations of FC is that exogenously added fluorophores are not the only source of fluorescence in a sample.
Autofluorescence (AF) can be, in some circumstances, a significant contributor to the signal present in each of
the detection channels, often overlapping with the emission spectra. AF limits assay sensitivity and causes
problems in data interpretation, which can lead to erroneous scientific conclusions. While several approaches
have been employed to eliminate AF, there are no satisfactory solutions available.
Kinetic River has been developing novel methods utilizing fluorescence lifetime (FLT) as an intrinsic
discriminating parameter and resolving multi-exponential lifetime decays in flow cytometry. In our completed
Phase I SBIR, we successfully demonstrated the automated removal of cellular AF interference in fluorophore-
labeled human cells using time-resolved emission lifetimes using a 4-color system, establishing feasibility of the
method. This Phase II grant will advance these findings towards commercialization by expanding the system into
a fully operational 16-color Colorado analyzer with real-time data processing. The successful completion of the
Colorado analyzer will lead to the first solution that automatically eliminates interference from AF in flow
cytometer experiments. It will become a game-changing platform enabling cell biologists, immunologists,
oncology researchers, diagnostic companies, and other FC users to obtain more accurate and quantitative
results. Removal of cellular AF interference will yield enhanced sensitivity, which is important for detecting rare
surface markers. This added capability of the Colorado platform will provide it with a significant competitive
advantage over current commercial FC analyzers of similar multiplexing capabilities. This will enable the
Colorado to replace current mid-level multiplexing instruments, which currently occupy a large swath of
the rapidly growing $4.8 billion FC market.
项目摘要/摘要
流式细胞术是一种强大的细胞分析工具,它依赖于细胞的荧光标记。它可以提供
关于细胞计数、形状、大小、DNA含量、氧化还原状态、膜通透性和表面受体的信息,
在其他功能中。Fc是肿瘤生物学研究和临床研究中必不可少的工具
以及艾滋病诊断、干细胞治疗、免疫表型和癌症免疫治疗。领军人物之一
FC的局限性在于,外源添加的荧光团不是样品中唯一的荧光来源。
在某些情况下,自体荧光(AF)可能是每种情况下存在的信号的重要贡献者
探测通道经常与发射光谱重叠。房颤限制检测灵敏度及其原因
数据解释中的问题,这可能导致错误的科学结论。虽然有几种方法
已经被用来消除房颤,但没有令人满意的解决方案。
Kineic River一直在开发利用荧光寿命(FLT)作为本征的新方法
流式细胞术中参数识别和多指数寿命衰减的解析。在我们完成的
在第一阶段SBIR中,我们成功地展示了在荧光团中自动消除细胞房颤干扰-
使用四色系统使用时间分辨的发射寿命来标记人类细胞,建立了
方法。这项第二阶段的拨款将通过将该系统扩展到
完全可操作的16色科罗拉多分析仪,具有实时数据处理功能。成功地完成了
科罗拉多州分析仪将带来第一个自动消除流动中房颤干扰的解决方案
细胞仪实验。它将成为一个改变游戏规则的平台,使细胞生物学家、免疫学家、
肿瘤学研究人员、诊断公司和其他FC用户获得更准确和定量的
结果。消除细胞房颤干扰将产生更高的灵敏度,这对于检测罕见的
曲面标记。科罗拉多平台的这一新增功能将为其提供显著的竞争优势
比目前具有类似多路复用能力的商用FC分析仪更具优势。这将使
科罗拉多州将取代目前的中层多路复用仪器,后者目前占据了大片地区
快速增长的48亿美元的FC市场。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Giacomo Vacca其他文献
Giacomo Vacca的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Giacomo Vacca', 18)}}的其他基金
Eliminating Interference from Autofluorescence in Flow Cytometry
消除流式细胞术中自发荧光的干扰
- 批准号:
10593113 - 财政年份:2022
- 资助金额:
$ 144.18万 - 项目类别:
Compensation-Free, Highly Multiplexed Flow Cytometer
无补偿、高度多重流式细胞仪
- 批准号:
9348516 - 财政年份:2017
- 资助金额:
$ 144.18万 - 项目类别:
Compensation-Free, Highly Multiplexed Flow Cytometer
无补偿、高度多重流式细胞仪
- 批准号:
9912775 - 财政年份:2017
- 资助金额:
$ 144.18万 - 项目类别:
相似海外基金
Computing analysis of leukemic stem cell dynamics in acute myelocytic leukemia
急性粒细胞白血病白血病干细胞动力学的计算分析
- 批准号:
19K08356 - 财政年份:2019
- 资助金额:
$ 144.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of immunotoxins with super-targeting mAb in the acute myelocytic leukemia
在急性髓细胞白血病中使用超靶向单克隆抗体产生免疫毒素
- 批准号:
23501309 - 财政年份:2011
- 资助金额:
$ 144.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556971 - 财政年份:1980
- 资助金额:
$ 144.18万 - 项目类别:
DETERMINANTS OF RESPONSE OF ACUTE MYELOCYTIC LEUKEMIA
急性粒细胞白血病反应的决定因素
- 批准号:
3556968 - 财政年份:1980
- 资助金额:
$ 144.18万 - 项目类别:
ERADICATION OF ACUTE MYELOCYTIC LEUKEMIA CELLS BY MAB THERAPY
通过 MAB 疗法根除急性粒细胞白血病细胞
- 批准号:
3889304 - 财政年份:
- 资助金额:
$ 144.18万 - 项目类别: